M1/M4-selective muscarinic agonists (Neurosolis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameM1/M4-selective muscarinic agonists (Neurosolis)
Drug Alias NameNSX-0527NSX-0559
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor M1 agonistsNeuroprotectantsMuscarinic acetylcholine receptor M4 agonists
TargetsMuscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M4
Therapy Area/IndicationsSchizophreniaPainAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeuroSolis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuroSolis Inc
Active IndicationsN/A
Inactive IndicationsSchizophreniaPainAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A